Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pharmacotherapeutic management of bipolar disorder has advanced considerably since the introduction of lithium therapy nearly 50 years ago. The sizable percentage of patients who do not respond adequately to lithium and/or are intolerant to its side effects has served as an impetus for identifying alternative pharmacotherapeutic agents. Recent advances in the understanding of the neurotransmitter systems and their receptors as it applies to treatment of bipolar disorder has, in part, led to progress in delineating applications of anticonvulsant/antiepileptic drugs (AEDs) in this area. Although the efficacy of many drugs has been evaluated in patients with this disorder, medication tolerability and adherence issues related to unfavorable side effect profiles are substantial impediments to the development of novel pharmacotherapies. The potential for excessive weight gain as a side effect of certain psychopharmacologic agents remains a concern to both clinicians and patients. METHOD: English-language literature from 1985-2001 in MEDLINE was searched for the terms bipolar disorder, anticonvulsant, antiepileptic, lithium, antipsychotic, weight, and compliance. This article reviewed current therapeutic options for bipolar disorder, including newer AEDs and atypical antipsychotic drugs, with emphasis on the issue of weight gain and possible approaches to minimizing this risk. RESULTS: Certain newer AEDs are characterized by more favorable safety and tolerability profiles that include weight loss as a desirable side effect. Because bipolar disorder is associated with unacceptably high rates of relapse, recurrence, and morbidity, the concept of pharmacotherapeutic efficacy logically not only includes symptom relief but also necessarily encompasses issues related to regimen tolerability and adherence. CONCLUSION: There is a need for guidelines to help physicians carefully formulate and individualize management plans to reach safe, effective, and cost-efficient patient outcomes. Monitoring the weight of patients with bipolar disorder and educating them regarding this issue should be standard components of any treatment plan.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The medications most commonly associated with weight gain are olanzapine, clozapine, risperidone, quetiapine, gabapentin, divalproex and lithium; with carbamazepine, lamotrigine, and ziprasidone being the safer or options associated with less weight gain.808”
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,362
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
Olanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Tohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
Pande, A. C., Crockatt, J. G., Janney, C. A., Werth, J. L., Tsaroucha, G., & Gabapentin Bipolar Disorder Study Group (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20305.x · Cited by 313
Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.4.431 · Cited by 266
Psychological Predictors of Insight and Compliance in Psychotic Patients
Kemp, R., & David, A. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.444 · Cited by 266
Clozapine for treatment-refractory mania
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.759 · Cited by 265
Hyperglycemia and antipsychotic medications.
Haupt, D. W., & Newcomer, J. W. (2001) · PubMed · Cited by 252
Segal, J., Berk, M., & Brook, S. (1998) · PubMed · Cited by 238
Open-label adjunctive topiramate in the treatment of bipolar disorders
McElroy, S. L., Suppes, T., Keck, P. E., Frye, M. A., Denicoff, K. D., Altshuler, L. L., Brown, E. S., Nolen, W. A., Kupka, R. W., Rochussen, J., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00316-9 · Cited by 210
Use of topiramate, a new anti-epileptic as a mood stabilizer
Marcotte, D. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00110-4 · Cited by 197
Adherence to antipsychotic medications.
Perkins, D. O. (1999) · PubMed · Cited by 193
Safety of Topiramate: Adverse Events and Relationships to Dosing
Shorvon, S. D. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06029.x · Cited by 184
The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders
Emrich, H. M., Dose, M., & von Zerssen, D. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90022-9 · Cited by 176
Lithium use and discontinuation in a health maintenance organization
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.993 · Cited by 173
The place of anticonvulsant therapy in bipolar illness
Post, R. M., Ketter, T. A., Denicoff, K. D., Pazzaglia, P. J., Leverich, G. S., Marangell, L. B., Callahan, A. M., George, M. S., & Frye, M. A. (1996) · Psychopharmacology · doi:10.1007/s002130050117 · Cited by 169
Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder
Calabrese, J. R., Bowden, C. L., McElroy, S. L., Cookson, J., Andersen, J., Keck, Jr., Rhodes, L., Bolden-Watson, C., Zhou, J., & Ascher, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1019 · Cited by 167
Bodyweight Change as an Adverse Effect of Drug Treatment: Mechanisms and Management
Pijl, H., & Meinders, A. E. (1996) · Drug Safety · doi:10.2165/00002018-199614050-00005 · Cited by 155
Factors associated with pharmacologic noncompliance in patients with mania.
Keck, P. E., McElroy, S. L., Strakowski, S. M., Stanton, S. P., Kizer, D. L., Balistreri, T. M., Bennett, J. A., Tugrul, K. C., & West, S. A. (1996) · PubMed · Cited by 154
Carbamazepine vs Lithium in the Treatment and Prophylaxis of Mania
Lusznat, R. M., Murphy, D. P., & Nunn, C. M. H. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.153.2.198 · Cited by 148
Weight gain associated with use of psychotropic medications.
Sachs, G. S., & Guille, C. (1999) · PubMed · Cited by 148
Prophylactic efficacy of carbamazepine in manic-depressive illness
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.12.1602 · Cited by 148
Placidi, G. F., Lenzi, A., Lazzerini, F., Cassano, G., & Akiskal, H. S. (1986) · PubMed · Cited by 142
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
Coxhead, N., Silverstone, T., & Cookson, J. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01453.x · Cited by 135
Clozapine in the Treatment of Refractory Psychotic Mania
Green, A. I., Tohen, M., Patel, J. K., Banov, M., DuRand, C., Berman, I., Chang, H., Zarate, C., Posener, J., Lee, H., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.982 · Cited by 134
Changes in Body Weight With Chronic, High-Dose Gabapentin Therapy
DeToledo, J. C., Toledo, C., DeCerce, J., & Ramsay, R. E. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199708000-00006 · Cited by 129
Lamotrigine in Rapid-Cycling Bipolar Disorder
Fatemi, S. H., Rapport, D. J., Calabrese, J. R., & Thuras, P. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1202 · Cited by 120
Clinical Factors Associated With Better Quality of Life in a Seriously Mentally Ill Population
Sullivan, G., Wells, K. B., & Leake, B. (1992) · Psychiatric Services · doi:10.1176/ps.43.8.794 · Cited by 112
Physical and psychological consequences of weight gain.
Kawachi, I. I. (1999) · PubMed · Cited by 108
Guille, C., Sachs, G. S., & Ghaemi, S. N. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0907 · Cited by 101
The interaction of patient perception of overmedication with drug compliance and side effects
Fincke, B. G., Miller, D. R., & Spiro, A. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00053.x · Cited by 98
Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania
Grunze, H., Erfurth, A., Marcuse, A., Amann, B., Normann, C., & Walden, J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1107 · Cited by 90
Harvey, N. S., & Peet, M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.2.200 · Cited by 82
The Use of Quetiapine for Treatment-Resistant Bipolar Disorder: A Case Series
Ghaemi, S. N., & Katzow, J. J. (1999) · Annals of Clinical Psychiatry · doi:10.3109/10401239909147062 · Cited by 79
A Pilot Study of Topiramate as Monotherapy in the Treatment of Acute Mania
Calabrese, J. R., Keck, P. E., McElroy, S. L., & Shelton, M. D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00015 · Cited by 75
Lamotrigine for the treatment of bipolar disorder: a clinical case series
Suppes, T. M., Brown, E. S., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Frye, M. A., Denicoff, K. D., Altshuler, L. L., Leverich, G. S., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00077-9 · Cited by 64
Lamotrigine in the treatment of bipolar depression
Bowden, C. L., Mitchell, P. B., & Suppes, T. M. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00024-3 · Cited by 61
Prescription Medications: A Modifiable Contributor to Obesity
CHESKIN, L. J., BARTLETT, S. J., ZAYAS, R., TWILLEY, C. H., ALLISON, D. B., & CONTOREGGI, C. (1999) · Southern Medical Journal · doi:10.1097/00007611-199909000-00009 · Cited by 57
Long-Term Prophylactic Effects of Carbamazepine in Affective Disorder
Kishimoto, A., Ogura, C., Hazama, H., & Inoue, K. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.4.327 · Cited by 55
Gury, C., Canceil, O., & Iaria, P. (2000) · PubMed · Cited by 54
Clinical Experience Using Adjunctive Gabapentin in Treatment-Resistant Bipolar Mixed States
Perugi, G., Toni, C., Ruffolo, G., Sartini, S., Simonini, E., & Akiskal, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979219 · Cited by 46
Baulac, M. (1998) · Seizure · doi:10.1016/s1059-1311(98)90009-7 · Cited by 45
Adjunctive Tiagabine Treatment of Psychiatric Disorders: Three Cases
Kaufman, K. R. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022350330567 · Cited by 45
Psychotherapy, medication combinations, and compliance.
Paykel, E. S. (1995) · PubMed · Cited by 43
Long Term Treatment of Bipolar Disorder
Silverstone, T., & Romans, S. E. (1996) · Drugs · doi:10.2165/00003495-199651030-00003 · Cited by 38
Martínez, J. A., Velasco, J. J., & Urbistondo, M. D. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718394 · Cited by 24
Short-term and long-term treatment for bipolar patients: beyond the guidelines
Mendlewicz, J., Souery, D., & Rivelli, S. K. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00125-1 · Cited by 21
Combining Lithium and Sodium Valproate for Bipolar Disorder
Mitchell, P. B., Withers, K., Jacobs, G. E., & Hickie, I. B. (1994) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679409075856 · Cited by 19
Lamotrigine for the Treatment of Bipolar Disorder
Engle, P. M., & Heck, A. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19128 · Cited by 13
Adler, L., Ulrich, M., Lehmann, K., Nordeck, I., Langer, C., Rs, T., Hajak, G., & Koller, M. (1996) · PubMed · Cited by 9
Cited by
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
STIGMA: BARRIER TO MENTAL HEALTH CARE AMONG ETHNIC MINORITIES
Gary, F. A. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840500280638 · Cited by 613
“Kafkaesque nightmares sometimes emerge within families as they ponder how, when, why, and under what circumstances these horrific illnesses occurred in their family members (Adshead, 2003; Anderson & Nickerson, 2005; Lefley, 1989; Nemeroff, 2003; Pinel, 1999; Szasz, 2003).”
BackgroundAsenapine: a novel psychopharmacologic agent with a unique human receptor signature
Shahid, M., Walker, G., Zorn, S., & Wong, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881107082944 · Cited by 493
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
Fagiolini, A., Frank, E., Scott, J. A., Turkin, S., & Kupfer, D. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00234.x · Cited by 449
Metadata
- Authors
- Nemeroff, C. B.
- Affiliations
- Emory University (US)
- Corresponding author
- Nemeroff, Charles B.
- ORCID
- Nemeroff, Charles B.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-05-15
- Volume
- 64
- Issue
- 5
- Pages
- 532-539
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2094246063
- Cited by
- 86
- References
- 55
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2014: 2 · 2013: 6 · 2012: 3
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, drug safety, lithium, atypical antipsychotics, weight gain, medication adherence, tolerability, weight loss, relapse prevention
- MeSH terms
- Topiramate, Anticonvulsants, Bipolar Disorder, Clinical Protocols, Female, Fructose, Humans, Lithium, Obesity, Patient Compliance, Patient Education as Topic, Antipsychotic Agents, Weight Gain, Weight Loss, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.